The “Gold Standard” of research, with double blind, case-controlled studies, shared in scientific journals helps physicians understand risks and benefits before our patients are exposed to a new chemical or a new pharmaceutical product. That “gold standard” simply cannot be met once a chemical is released into the environment and the public is exposed to it. With lead, there was nothing new. There are years of research showing that no level of lead is safe in our body. Yet, the actual research about lead exposure from lipstick is limited, and does not look at exposure from multiple sources simultaneously. The assumption is that the amounts are small, so harm is negligible. The assumptions are the same for all personal care products: if they cannot be proven individually to cause harm once they are on the market, there is no reason to remove them from use. Historically, there is no cumulative exposure concept. We as consumers should ask for a higher standard. The International Federation of Gynecology and Obstetrics (FIGO) called for just that approach on a global perspective. The American Congress of Obstetricians and Gynecologists called for reform in the United States.